AMG Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2023
Company reports EPS of $5.48, Economic EPS of $4.08 in the third quarter of 2023 Completed investment in Ara Partners,...
Read moreCompany reports EPS of $5.48, Economic EPS of $4.08 in the third quarter of 2023 Completed investment in Ara Partners,...
Read more- Topline Data from Zunsemetinib Phase 2b Trial in Rheumatoid Arthritis Expected this Month – - Completion of Enrollment in...
Read moreSynaptics Senior Vice President and General Manager to Join Lantronix Effective November 20, 2023 President and CEO Lantronix announced that...
Read more– First cleared CD19-CAR T IND application for generalized myasthenia gravis announced in the U.S. and fourth IND clearance for...
Read moreStriim, Inc. Celebrated as a Great Place to Work in 2023! Striim, Inc., a leader in real-time data for Generative...
Read moreExpands capacity for multi-asset manufacturing with highly accomplished supply chain, manufacturing and quality control leader bringing more than 25 years...
Read morePreference of People to Select Natural Options When it Comes to Food Products Fueling Demand in the Gum Hydrocolloid Market...
Read moreKey zinc oxide market players include Umicore N.V., EverZinc, Weifang Longda Zinc Industry Co., Ltd., GH Chemicals Limited, Rubamin Ltd.,...
Read moreLONDON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...
Read morePresented novel preclinical data showing that CoStAR enhances activity of CD4+ T cells in multiple ways to broaden anti-tumor response...
Read more